Search Results - "Nix, B. D."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Genetic variation in the beta‐2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health‐related quality of life by Kushnir, V. M., Cassell, B., Gyawali, C. P., Newberry, R. D., Kibe, P., Nix, B. D., Sabzpoushan, A., Kanuri, N. D., Sayuk, G. S.

    Published in Alimentary pharmacology & therapeutics (01-08-2013)
    “…Summary Background The beta‐2 adrenergic receptor (ADRB2) is an important target for epinephrine, a neurotransmitter in pain signalling. ADRB2 haplotypes…”
    Get full text
    Journal Article
  2. 2

    Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration by Sayuk, G. S., Kanuri, N., Gyawali, C. P., Gott, B. M., Nix, B. D., Rosenheck, R. A.

    Published in Alimentary pharmacology & therapeutics (01-03-2018)
    “…Summary Background While opioid prescriptions have increased alarmingly in the United States (US), their use for unexplained chronic gastrointestinal (GI) pain…”
    Get full text
    Journal Article
  3. 3

    Genetic risk factors for perception of symptoms in GERD: an observational cohort study by Patel, A., Hasak, S., Nix, B. D., Sayuk, G. S., Newberry, R. D., Gyawali, C. P.

    Published in Alimentary pharmacology & therapeutics (01-01-2018)
    “…Summary Background Genetic polymorphisms in G‐protein beta‐3 subunit (GNβ3) and beta‐2 adrenergic receptor (ADRB2) are associated with pain and gut…”
    Get full text
    Journal Article
  4. 4

    Improvement in Sexual Functioning in Patients With Type 2 Diabetes and Depression Treated With Bupropion by SAYUK, Gregory S, GOTT, Britt M, NIX, Billy D, LUSTMAN, Patrick J

    Published in Diabetes care (01-02-2011)
    “…Major depressive disorder (MDD) and type 2 diabetes have independent adverse effects on sexual functioning (SF). Bupropion (BU) reportedly has few sexual side…”
    Get full text
    Journal Article
  5. 5

    Sertraline for Prevention of Depression Recurrence in Diabetes Mellitus: A Randomized, Double-blind, Placebo-Controlled Trial by Lustman, Patrick J, Clouse, Ray E, Nix, Billy D, Freedland, Kenneth E, Rubin, Eugene H, McGill, Janet B, Williams, Monique M, Gelenberg, Alan J, Ciechanowski, Paul S, Hirsch, Irl B

    Published in Archives of general psychiatry (01-05-2006)
    “…CONTEXT In patients with diabetes mellitus, depression is a prevalent and recurrent problem that adversely affects the medical prognosis. OBJECTIVE To…”
    Get full text
    Journal Article